Baiyan Wang

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 526 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +19

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

Yuanfang Liu, Baiyan Wang, Weina Zhang et al. · EBioMedicine · 2016 · 333 citations · Full text

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Wanhong Zhao, Baiyan Wang, Lijuan Chen et al. · Journal of Hematology & Oncology · 2022 · 139 citations · Full text

Management of cytokine release syndrome related to CAR-T cell therapy

Hongli Chen, Fangxia Wang, Pengyu Zhang et al. · Frontiers of Medicine · 2019 · 106 citations

Inflammation, Autoimmune Disease, T-regulatory Cell +7

Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway

Yanhui Zhu, Qianqian Han, Lei Wang et al. · Journal of Ethnopharmacology · 2022 · 67 citations · Full text